ACS sets goal to cut cancer mortality 40 percent by 2035

(HealthDay)—The American Cancer Society (ACS) has set a goal of a 40 percent reduction in overall cancer mortality by 2035, according to a study published online May 8 inCA: A Cancer Journal for

Updated on: March 27,2024

ACS sets goal to cut cancer mortality 40 percent by 2035

(HealthDay)—The American Cancer Society (ACS) has set a goal of a 40 percent reduction in overall cancer mortality by 2035, according to a study published online May 8 inCA: A Cancer Journal for

Updated on:March 27,2024

Markups for oncology services vary at the hospital level

(HealthDay)—There is significant variation in markup of outpatient oncology services across hospitals in the United States, according to a study published online Feb. 17 in theAmerican Journal o

Updated on: April 09,2024

Markups for oncology services vary at the hospital level

(HealthDay)—There is significant variation in markup of outpatient oncology services across hospitals in the United States, according to a study published online Feb. 17 in theAmerican Journal o

Updated on:April 09,2024

Swallowable device to detect Barrett's esophagus receives FDA 510(k) clearance

by Case Western Reserve University"FDA clearance of the EsoCheck device means the device is now available to patients and physicians as a non-endoscopic method for sampling the esophagus. Th

Updated on: May 09,2024

Swallowable device to detect Barrett's esophagus receives FDA 510(k) clearance

by Case Western Reserve University"FDA clearance of the EsoCheck device means the device is now available to patients and physicians as a non-endoscopic method for sampling the esophagus. Th

Updated on:May 09,2024

CAR T cell therapy may eliminate tumor cells missed by surgery

by Perelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainCAR T cell therapy, an approach which reprograms patients' own immune cells to attack their blood canc

Updated on: April 09,2024

CAR T cell therapy may eliminate tumor cells missed by surgery

by Perelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainCAR T cell therapy, an approach which reprograms patients' own immune cells to attack their blood canc

Updated on:April 09,2024

A sustainable diagnosis tool for multiple cancers

byNature Publishing GroupValidation via cancers diagnosis. Credit:Nature Sustainability(2024). DOI: 10.1038/s41893-024-01323-9An accurate, affordable, environmentally and user-friend

Updated on: April 28,2024

A sustainable diagnosis tool for multiple cancers

byNature Publishing GroupValidation via cancers diagnosis. Credit:Nature Sustainability(2024). DOI: 10.1038/s41893-024-01323-9An accurate, affordable, environmentally and user-friend

Updated on:April 28,2024

Multiple recurrent, repeat expansions found in human cancer genomes

by Bob Yirka , Medical XpressGenome-wide detection of rREs in cancer genomes. a, Scheme of the method to identify rREs in 2,509 patients across 29 human cancer types: 1, head and neck squamous cell ca

Updated on: February 18,2024

Multiple recurrent, repeat expansions found in human cancer genomes

by Bob Yirka , Medical XpressGenome-wide detection of rREs in cancer genomes. a, Scheme of the method to identify rREs in 2,509 patients across 29 human cancer types: 1, head and neck squamous cell ca

Updated on:February 18,2024

Study hints at new target to improve immune therapy in triple-negative breast cancer

by CU Anschutz Medical CampusHeide Ford, PhD, and University of Colorado Cancer Center colleagues show that Eya3 may regulate immune response to triple-negative breast cancer, potentially improvi

Updated on: June 01,2024

Study hints at new target to improve immune therapy in triple-negative breast cancer

by CU Anschutz Medical CampusHeide Ford, PhD, and University of Colorado Cancer Center colleagues show that Eya3 may regulate immune response to triple-negative breast cancer, potentially improvi

Updated on:June 01,2024

Team discovers gene mutations linked to pancreatic cancer

by Susan Buckles,Mayo ClinicCredit: Mayo ClinicSix genes contain mutations that may be passed down in families, substantially increasing a person's risk for pancreatic cancer. That's acc

Updated on: May 27,2024

Team discovers gene mutations linked to pancreatic cancer

by Susan Buckles,Mayo ClinicCredit: Mayo ClinicSix genes contain mutations that may be passed down in families, substantially increasing a person's risk for pancreatic cancer. That's acc

Updated on:May 27,2024

Researchers probe microbiome-cancer treatment link

by Nathan Collins,Stanford UniversityCredit: CC0 Public DomainCancer immunotherapies have given patients with particularly intractable cancers new hope, but not everyone benefits. One such immun

Updated on: June 06,2024

Researchers probe microbiome-cancer treatment link

by Nathan Collins,Stanford UniversityCredit: CC0 Public DomainCancer immunotherapies have given patients with particularly intractable cancers new hope, but not everyone benefits. One such immun

Updated on:June 06,2024

A barrier that keeps cancer at bay

by Ecole Polytechnique Federale de LausanneLoss of a barrier to tumor formation: On the left, a protective barrier of activin B expression (red color) is present in normal pancreatic islets. On t

Updated on: March 27,2024

A barrier that keeps cancer at bay

by Ecole Polytechnique Federale de LausanneLoss of a barrier to tumor formation: On the left, a protective barrier of activin B expression (red color) is present in normal pancreatic islets. On t

Updated on:March 27,2024

Scientists pinpoint gene to blame for poorer survival rate in early-onset breast cancer patients

by University of SouthamptonMammograms showing a normal breast (left) and a cancerous breast (right). Credit: Wikipedia.A new study led by scientists at the University of Southampton has found th

Updated on: March 01,2024

Scientists pinpoint gene to blame for poorer survival rate in early-onset breast cancer patients

by University of SouthamptonMammograms showing a normal breast (left) and a cancerous breast (right). Credit: Wikipedia.A new study led by scientists at the University of Southampton has found th

Updated on:March 01,2024

ASH: A+AVD beats ABVD for advanced Hodgkin's lymphoma

(HealthDay)—For patients with advanced-stage Hodgkin's lymphoma, brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine (A+AVD) have superior efficacy to doxorubicin, bleomycin, vinblastin

Updated on: March 30,2024

ASH: A+AVD beats ABVD for advanced Hodgkin's lymphoma

(HealthDay)—For patients with advanced-stage Hodgkin's lymphoma, brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine (A+AVD) have superior efficacy to doxorubicin, bleomycin, vinblastin

Updated on:March 30,2024